| Literature DB >> 25821483 |
Bongki Park1, Sooseong You1, Jeeyoun Jung1, Ju Ah Lee1, Kyung-Jin Yun1, Myeong Soo Lee1.
Abstract
Blood stasis is one of the important pathological concepts in Korean medicine. We analyzed the Korean studies concerning blood stasis. We searched for articles in eight electronic databases from their inception to September, 2014. We included reviews, clinical studies, and preclinical studies that had studied blood stasis and excluded articles in which blood stasis was not mentioned or in which the original authors had not explained blood stasis. Of 211 total included studies, 19 were reviews, 52 were clinical studies, and 140 were preclinical articles. "Stagnant blood within the body" was the most frequently mentioned phrase of the traditional concept of blood stasis. Traumatic injury was the most frequently studied disease/condition in the clinical studies. In the preclinical studies, coagulopathy was studied most frequently, followed by hyperviscosity, hyperlipidemia, inflammation, neoplasm, ischemic brain injury, and atherosclerosis. Hyeolbuchukeo-tang and Angelicae Gigantis Radix were the most frequent formula and single herb, respectively, used in the blood stasis researches. The results showed that blood stasis was mainly recognized as disorder of circulation and many studies showed the effectiveness of activating blood circulating herbs for diseases and pathologies such as traumatic injury or coagulopathy. Further studies are needed in the pathologic mechanisms and various diseases of blood stasis.Entities:
Year: 2015 PMID: 25821483 PMCID: PMC4363678 DOI: 10.1155/2015/316872
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow diagram of study selection for qualitative analysis.
Figure 2The number of articles according to the year of publication.
The concepts, diseases, and pathology regarding blood stasis in the reference articles.
| Total articles | Review articles | Clinical articles | Preclinical articles | |
|---|---|---|---|---|
| Concept | ||||
|
| ||||
| Stagnant blood within the body | 97 | 16 | 7 | 18 |
| Disorder of blood circulation | 92 | 18 | 3 | 24 |
| Pathological product | 84 | 12 | 11 | 61 |
| Loss of physiological function | 67 | 8 | 8 | 51 |
| Pathogenic factor | 54 | 9 | 8 | 37 |
| Extravasated blood | 36 | 8 | 8 | 19 |
| Foul blood | 30 | 5 | 2 | 23 |
| Blood congested in viscera and tissue | 27 | 7 | 8 | 13 |
| The blood circulating sluggishly | 25 | 2 | 2 | 22 |
| Blood congested in a blood vessel | 21 | 5 | 3 | 13 |
| Organ dysfunction | 20 | 4 | 16 | |
| Stagnation of blood flow in local parts | 6 | 1 | 5 | |
|
| ||||
| Disease/condition/pathology | ||||
|
| ||||
| Coagulopathy | 91 | |||
| Hyperviscosity | 33 | |||
| Inflammation | 23 | |||
| Hyperlipidemia | 21 | |||
| Oxidant stress | 12 | |||
| Pain | 10 | |||
| Liver injury | 10 | |||
| Traumatic injury | 19 | 9 | ||
| Neoplasm | 9 | |||
| Ischemic brain injury | 9 | |||
| Atherosclerosis | 8 | |||
| Hypertension | 6 | |||
| Diabetes mellitus | 6 | |||
| Nephropathy | 6 | |||
| Hematoma | 2 | |||
| Genitourinary | 11 | |||
| Cerebrovascular accident | 8 | |||
| Musculoskeletal disorder | 4 | |||
| Etc. | 8 | |||
|
| ||||
| Herbal formula | ||||
|
| ||||
| Hyeolbuchukeo-tang ( | 12 | 2 | 10 | |
| Jungseongeohyeol-pharmacopuncture (中性 | 9 | 5 | 4 | |
| Gyeokhachukeo-tang (膈下 | 6 | 6 | ||
| Gyezibokryeong-whan ( | 7 | 2 | 5 | |
| Dangkwisoo-san ( | 6 | 1 | 5 | |
|
| ||||
| Herb | ||||
|
| ||||
| Angelicae Gigantis Radix | 107 | 19 | 88 | |
| Persicae Semen | 99 | 22 | 77 | |
| Carthami Flos | 84 | 19 | 65 | |
| Paeoniae Radix Rubra | 82 | 20 | 62 | |
| Cnidii Rhizoma | 79 | 14 | 65 | |
| Glycyrrhizae Radix | 65 | 13 | 52 | |
| Cyperi Rhizoma | 44 | 10 | 34 | |
| Corydalis Tuber | 40 | 9 | 31 | |
| Sappan Lignum | 35 | 12 | 23 | |
| Achyranthis Radix | 34 | 9 | 25 | |
| Moutan Cortex Radicis | 31 | 5 | 26 | |
| Salviae Miltiorrhizae Radix | 30 | 8 | 22 | |
| Myrrha | 29 | 9 | 20 | |
| Rehmanniae Radix | 29 | 8 | 21 | |
| Linderae Radix | 26 | 7 | 19 | |
The significant indicators investigated by ABC herbs in the preclinical studies.
| Disease/pathology | Significant indicators (by ABC herbs) |
|---|---|
| Coagulopathy | RBC, WBC, PLT, hematocrit, fibrinogen, FDP, fibrinolytic activity, PLT aggregation, PT, aPTT, clotting time, prostaglandin synthase, PGE2, TBXA2, GPIIb/IIIa |
|
| |
| Hyperviscosity | Whole blood viscosity, plasma viscosity |
|
| |
| Hyperlipidemia | Total cholesterol, triglyceride, phospholipid, AST, ALT, HDL, LDL, VLDL, leptin, adiponectin, free fatty acid, lipoprotein |
|
| |
| Inflammation | Edema, exudate, body weight, IL-1b, IL-6, IL-10, TNF-alpha, NO, PGE2, elastase activity, mast cell, WBC, MCP-1, COX-2 |
|
| |
| Neoplasm | Angiogenesis, pulmonary colonization of cancer cells, survival time, lymphocyte proliferation, NK cytotoxicity, apoptosis, tumor weight |
|
| |
| Ischemic brain injury | Coma duration, mortality, ischemic area, edema area, neurologic grade |
|
| |
| Atherosclerosis | Plaque size, histologic injury of aorta, lipid infiltration, membrane thickness |
|
| |
| Traumatic injury | Neurological motor behavioral test, apoptosis, edema, |
|
| |
| Oxidant stress | NO, ROS, superoxide, SOD |
|
| |
| Pain | Response time, writhing syndrome |
|
| |
| Hypertension | BP, dopamine, epinephrine, norepinephrine, NO, aldosterone, renin |
|
| |
| Diabetes mellitus | Glucose |
|
| |
| Nephropathy | 24-hour urine protein, albumin, creatinine |
|
| |
| Liver injury | ALP, LDL, LAP, AST, ALT, albumin |
ABC: ALP: alkaline phosphatase; ALT: alanine transaminase; aPTT: activated partial thromboplastin time; AST: aspartate transaminase; BP: blood pressure; COX: cyclooxygenase; FDP: fibrin degradation product; GP: glycoprotein; HDL: high density lipoprotein; IL: interleukin; LAP: leucine amino-peptidase; LDL: low density lipoprotein; MCP-1: monocyte chemotactic protein-1; NK: natural killer; NO: nitric oxide; PGE2: prostaglandin E2; PLT: platelet; PT: prothrombin time; RBC: red blood cell; ROS: reactive oxygen species; SOD: superoxide dismutase; TBXA2: thromboxane A2; TNF: tumor necrosis factor; VLDL: very low density lipoprotein; WBC: white blood cell.
Figure 3The relationship between the concept of blood stasis with pathology and diseases/conditions through the review. The sizes of the node, and line are emphasized by the frequency of quoted articles. The red nodes indicate the traditional concept of blood stasis.